These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 1374318)

  • 1. Current role of chemotherapy in head and neck cancer.
    Tobias JS
    Drugs; 1992 Mar; 43(3):333-45. PubMed ID: 1374318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of chemotherapy with radiotherapy: review of previous studies and new perspectives.
    Clavel M; Ardiet JM; Gignoux B
    Int J Clin Pharmacol Res; 1985; 5(4):279-82. PubMed ID: 2414237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Chemotherapy of head and neck cancer].
    Kohno N; Nakazawa E; Kusunoki M; Nishiya M
    Gan To Kagaku Ryoho; 1996 Feb; 23(3):277-82. PubMed ID: 8712819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemotherapy in head and neck cancer.
    Hamasaki VK; Vokes EE
    Curr Opin Oncol; 1992 Jun; 4(3):504-11. PubMed ID: 1498159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotherapy for head and neck cancer. Comparison of cisplatin + vinblastine + bleomycin versus methotrexate.
    Williams SD; Velez-Garcia E; Essessee I; Ratkin G; Birch R; Einhorn LH
    Cancer; 1986 Jan; 57(1):18-23. PubMed ID: 2416423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changing role of chemotherapy in treatment of head and neck cancer.
    Mead GM; Jacobs C
    Am J Med; 1982 Oct; 73(4):582-95. PubMed ID: 6181680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Role of Chemotherapy in head and neck cancer].
    Kohno N; Kitahara S
    Gan To Kagaku Ryoho; 2001 Apr; 28(4):448-53. PubMed ID: 11329777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neoadjuvant and adjuvant methotrexate, cisplatin, and fluorouracil in multimodal therapy of head and neck cancer.
    Vokes EE; Moran WJ; Mick R; Weichselbaum RR; Panje WR
    J Clin Oncol; 1989 Jul; 7(7):838-45. PubMed ID: 2661732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemotherapy in cancer of the head and neck.
    O'Donoghue GM; Hong WK
    Ir Med J; 1986 Jan; 79(1):20-3. PubMed ID: 2419276
    [No Abstract]   [Full Text] [Related]  

  • 10. Chemotherapy of squamous cell carcinoma of the head and neck.
    Greenberg BR
    Ariz Med; 1985 Jul; 42(7):411-7. PubMed ID: 2412534
    [No Abstract]   [Full Text] [Related]  

  • 11. [Critical remarks on chemotherapy of malignant tumors of the head and neck].
    Ganzer U; Bier H; Bachert C
    Laryngol Rhinol Otol (Stuttg); 1987 Apr; 66(4):200-4. PubMed ID: 2439860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of squamous cell carcinoma of the head and neck with multi-drug chemotherapy and radiotherapy].
    Nishio M; Kagami Y; Narimatsu N; Asano K; Sanbe S; Somekawa Y
    Gan To Kagaku Ryoho; 1989 Sep; 16(9):3111-8. PubMed ID: 2476971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Future directions in the chemotherapy of head and neck cancer.
    Grunberg SM
    Am J Clin Oncol; 1985 Feb; 8(1):51-4. PubMed ID: 2581435
    [No Abstract]   [Full Text] [Related]  

  • 14. A randomized phase III trial of cisplatinum, methotrexate, cisplatinum + methotrexate, and cisplatinum + 5-fluoro-uracil in end-stage head and neck cancer.
    Campbell JB; Dorman EB; McCormick M; Miles J; Morton RP; Rugman F; Stell PM; Stoney PJ; Vaughan ED; Wilson JA
    Acta Otolaryngol; 1987; 103(5-6):519-28. PubMed ID: 3303823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pretreatment with chemotherapy in patients with advanced head and neck cancer.
    Cripps C; Odell P; Danjoux C; Nichol J; de la Bastide Y; Barron P; Hardie J
    J Otolaryngol; 1985 Dec; 14(6):391-3. PubMed ID: 2416947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemotherapy and radiation therapy for laryngeal cancer.
    Hall SW; Miercort RD
    Semin Speech Lang; 1995 Aug; 16(3):233-9. PubMed ID: 7584811
    [No Abstract]   [Full Text] [Related]  

  • 17. Nursing implications related to chemotherapy for head and neck cancer.
    Newton M; Wulf BG
    Plast Surg Nurs; 1985; 5(4):135-41. PubMed ID: 2421366
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of recurrent head and neck cancer with cisplatin and 5-fluorouracil vs. the same plus bleomycin and methotrexate.
    Amrein PC; Fabian RL
    Laryngoscope; 1992 Aug; 102(8):901-6. PubMed ID: 1379664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methotrexate, vinblastine, epidoxorubicin, and bleomycin as second-line chemotherapy for recurrent and/or metastatic squamous cell carcinoma of the head and neck.
    Gebbia V; Valenza R; Testa A; Borsellino N; Cannata G; Restivo S; Speciale R; Ingria F; Spadafora G; Gebbia N
    ORL J Otorhinolaryngol Relat Spec; 1994; 56(5):279-82. PubMed ID: 7526312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors for chemotherapy response and survival using combination chemotherapy as initial treatment of advanced head and neck squamous cell cancer.
    Cognetti F; Pinnarö P; Ruggeri EM; Carlini P; Perrino A; Impiombato FA; Calabresi F; Chilelli MG; Giannarelli D
    J Clin Oncol; 1989 Jul; 7(7):829-37. PubMed ID: 2472469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.